Skip to content
Nonprofiteer
← PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Form 990 for tax year 2024

Filed by PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA.

Totals

Total revenue
$521,348,217
Total expenses
$578,265,057
Contributions and grants received
$1,116,000
Grants paid
$43,264,315
Program service revenue
$507,993,172
Investment income
$11,851,925
Other revenue
$387,120
Total assets, end of year
$349,012,370
Total liabilities, end of year
$190,475,115
Net assets or fund balances, end of year
$158,537,255
Program services expenses (Part IX)
not reported
Management and general expenses
not reported
Fundraising expenses
not reported
Program service expenses (Part III)
$0

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1f · All other contributions, gifts and grants

    $1,116,000

  • 2a · Program service revenue: MEMBERSHIP DUES

    total $508,650,143 · related or exempt $508,650,143

  • 2b · Program service revenue: MEETINGS, SECTIONS, STUDIES

    total -$656,971 · related or exempt -$656,971

  • 2f · All other program service revenue

    total $0 · related or exempt $0 · unrelated business $0 · excluded $0

  • 3 · Investment income

    total $11,921,705 · excluded $11,921,705

  • 6c · Rental income or loss

    real property $0 · personal property $0

  • 7a · Gross sales of assets other than inventory

    securities $3,471,628

  • 7b · Less cost or other basis and sales expenses

    securities $3,379,957 · other assets $161,451

  • 7c · Gain or loss

    securities $91,671 · other assets -$161,451

  • 7d · Net gain or loss

    total -$69,780 · excluded -$69,780

  • 11a · Other revenue: MISCELLANEOUS REVENUE

    total $387,120 · excluded $387,120

  • 11d · All other revenue

    total $0 · related or exempt $0 · unrelated business $0 · excluded $0

  • 11e · Other revenue, total

    $387,120

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $43,220,385

  • 3 · Grants to foreign organizations and individuals

    total $43,930

  • 4 · Benefits paid to or for members

    total $0

  • 5 · Compensation of officers, directors and key employees

    total $23,765,282

  • 7 · Other salaries and wages

    total $71,694,936

  • 8 · Pension plan contributions

    total $4,456,530

  • 9 · Other employee benefits

    total $6,427,347

  • 10 · Payroll taxes

    total $6,658,410

  • 11b · Fees: legal

    total $20,599,243

  • 11c · Fees: accounting

    total $315,609

  • 11d · Fees: lobbying

    total $167,952,424

  • 11f · Fees: investment management

    total $265,836

  • 11g · Fees: other

    total $82,010,503

  • 12 · Advertising and promotion

    total $27,283,713

  • 13 · Office expenses

    total $3,005,251

  • 14 · Information technology

    total $1,823,708

  • 16 · Occupancy

    total $13,985,438

  • 17 · Travel

    total $4,809,997

  • 19 · Conferences, conventions and meetings

    total $3,976,183

  • 22 · Depreciation, depletion and amortization

    total $3,399,116

  • 23 · Insurance

    total $719,108

  • 24a · Other expenses: MEMBERSHIPS

    total $68,250,478

  • 24b · Other expenses: RESEARCH STUDIES

    total $16,652,218

  • 24c · Other expenses: EQUIPMENT EXPENSE

    total $4,300,526

  • 24d · Other expenses: TAXES-OTHER

    total $2,356,120

  • 24e · All other expenses

    total $292,766

Balance sheet

Part X, book values.

  • 2 · Savings and temporary cash investments

    beginning of year $221,437,642 · end of year $38,462,581

  • 4 · Accounts receivable

    beginning of year $1,364,512 · end of year $1,129,636

  • 5 · Loans and receivables from officers and key people

    beginning of year $0 · end of year $0

  • 6 · Loans and receivables from disqualified persons

    beginning of year $0 · end of year $0

  • 9 · Prepaid expenses and deferred charges

    beginning of year $3,896,851 · end of year $4,230,134

  • 10a · Land, buildings and equipment: cost or other basis

    $41,789,403

  • 10b · Land, buildings and equipment: accumulated depreciation

    $11,269,989

  • 10c · Land, buildings and equipment, net

    beginning of year $25,409,340 · end of year $30,519,414

  • 11 · Investments: publicly traded securities

    beginning of year $80,262,649 · end of year $90,734,870

  • 12 · Investments: other securities

    beginning of year $10,811,296 · end of year $133,129,416

  • 13 · Investments: program-related

    beginning of year $0

  • 15 · Other assets

    beginning of year $55,768,387 · end of year $50,806,319

  • 17 · Accounts payable and accrued expenses

    beginning of year $56,663,492 · end of year $63,269,111

  • 19 · Deferred revenue

    beginning of year $33,997,527 · end of year $29,904,508

  • 22 · Loans and payables to officers and key people

    beginning of year $0 · end of year $0

  • 25 · Other liabilities

    beginning of year $97,360,691 · end of year $97,301,496

  • 27 · Net assets without donor restrictions

    beginning of year $210,928,967 · end of year $158,537,255

Mission and programs · 2024

Mission

PHRMA'S MISSION IS TO CONDUCT EFFECTIVE ADVOCACY FOR PUBLIC POLICIES THAT ENCOURAGE THE DISCOVERY OF IMPORTANT, NEW MEDICINES FOR PATIENTS BY BIOPHARMACEUTICAL RESEARCH COMPANIES.

Activities or mission (Part I)

PHRMA'S MISSION IS TO CONDUCT EFFECTIVE ADVOCACY FOR PUBLIC POLICIES THAT ENCOURAGE THE DISCOVERY OF IMPORTANT NEW MEDICINES FOR PATIENTS BY BIOPHARMACEUTICAL RESEARCH COMPANIES.

  • PUBLIC POLICY ADVOCACY: PHRMA'S MISSION IS TO CONDUCT EFFECTIVE ADVOCACY FOR PUBLIC POLICIES THAT ENCOURAGE DISCOVERY OF IMPORTANT NEW MEDICINES FOR PATIENTS BY BIOPHARMACEUTICAL RESEARCH COMPANIES. PHRMA ACHIEVES THIS MISSION BY WORKING WITH, AND ON BEHALF OF, ITS MEMBER COMPANIES BEFORE GOVERNMENTAL AND REGULATORY BODIES IN THE UNITED STATES AND THROUGHOUT THE WORLD IN SUPPORT OF PRO-PATIENT, PRO-INNOVATION POLICIES. SPECIFICALLY, PHRMA ADVOCATES FOR BROAD PATIENT ACCESS TO SAFE AND EFFECTIVE MEDICINES THROUGH A FREE MARKET, WITHOUT GOVERNMENT PRICE CONTROLS; STRONG INTELLECTUAL PROPERTY INCENTIVES; AND TRANSPARENT, EFFICIENT REGULATION AND A FREE FLOW OF INFORMATION TO PATIENTS.

  • MEMBER SERVICES: IN REPRESENTING THE COUNTRY'S LEADING PHARMACEUTICAL RESEARCH AND BIOTECHNOLOGY COMPANIES, PHRMA PROVIDES A FORUM FOR MEMBER COMPANIES TO PARTICIPATE IN DISCUSSIONS OF RELEVANT HEALTH CARE ISSUES AND TO DEVELOP CONSENSUS POSITIONS ON MATTERS OF PUBLIC POLICY ADVOCACY. MEMBER COMPANIES PARTICIPATE IN PHRMA ACTIVITIES THROUGH REPRESENTATION ON THE BOARD OF DIRECTORS, BOARD-LEVEL COMMITTEES, STAFF WORK GROUPS, SECTIONS, AND TASK FORCES. MEMBER COMPANY REPRESENTATIVES ALSO REGULARLY COMMUNICATE WITH PHRMA STAFF.

  • GENERAL EDUCATION ABOUT BIOPHARMACEUTICAL INDUSTRY: PHRMA DISSEMINATES INFORMATION ABOUT BIOPHARMACEUTICAL COMPANIES, THEIR PRODUCTS, AND THEIR BUSINESS, SCIENTIFIC AND PHILANTHROPIC ACTIVITIES THROUGH A WIDE RANGE OF CHANNELS, INCLUDING PROFILES, REPORTS, PRINCIPLES, GUIDELINES, FACT SHEETS, POLICY PAPERS AND OTHER RESOURCES. THESE EFFORTS BOLSTER PHRMA'S ABILITY TO EDUCATE AND INFORM MEMBERS OF THE GENERAL PUBLIC AS WELL AS POLICYMAKERS, THE MEDIA, PATIENTS AND OTHERS IN THE HEALTH CARE COMMUNITY ABOUT THE BIOPHARMACEUTICAL INDUSTRY AND PHRMA'S PUBLIC POLICY ACTIVITIES IN PARTICULAR.

As filed on the 2024 return.

Listed in Part VII

  • Albert Bourla PHD

    VICE CHAIR

    Total calculated
    $0
    Hours/week
    2
  • Daniel O' Day

    CHAIR

    Total calculated
    $0
    Hours/week
    2
  • Paul Hudson

    TREASURER

    Total calculated
    $0
    Hours/week
    2
  • Stephen J Ubl

    President & CEO

    Total calculated
    $7,643,016
    From this org
    $5,935,826
    From related orgs
    $0
    Other
    $1,707,190
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $2,330,915
    Bonus
    $3,010,587
    Other
    $594,324
    Deferred
    $1,669,515
    Nontaxable benefits
    $37,675
    Filer's total
    $7,643,016
  • Alexander Hardy

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Anthony Mancini

    DIRECTOR (THRU 08/24)

    Total calculated
    $0
    Hours/week
    2
  • Ashley Magargee

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Barry Greene

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Bob Lojewski

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Brad Bailey

    DIRECTOR (AS OF 08/24)

    Total calculated
    $0
    Hours/week
    2
  • Chris Boerner PHD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Chris ROUND

    DIRECTOR (THRU 12/24)

    Total calculated
    $0
    Hours/week
    2
  • Chris Viehbacher

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • David Loew

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • David Ricks

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Douglas L Langa

    DIRECTOR (THRU 12/24)

    Total calculated
    $0
    Hours/week
    2
  • Emma Walmsley

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Herve J Hoppenot

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Jean-Christophe Tellier MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Jean-Michel Boers

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Jennifer Taubert

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Julie Kim

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Ken Keller

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • KEVIN C GORMAN PhD

    DIRECTOR (THRU 09/24)

    Total calculated
    $0
    Hours/week
    2
  • Kyle Gano PHD

    DIRECTOR (AS OF 10/24)

    Total calculated
    $0
    Hours/week
    2
  • Mark Reisenauer

    DIRECTOR (THRU 04/24)

    Total calculated
    $0
    Hours/week
    2
  • Michael Petroutsas

    DIRECTOR (AS OF 02/24)

    Total calculated
    $0
    Hours/week
    2
  • Myrtle Potter

    DIRECTOR (THRU 03/24)

    Total calculated
    $0
    Hours/week
    2
  • Richard F Pops

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Robert A Bradway

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Robert M Davis

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Sebastian Guth PHD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Tarek Rabah

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Tatsuyki Yasuno

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Thomas Gibbs

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Vasant Vas Narasimhan MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • James C Stansel

    General Counsel & EVP Law, Secretary

    Total calculated
    $2,266,858
    From this org
    $1,761,157
    From related orgs
    $0
    Other
    $505,701
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $853,954
    Bonus
    $901,733
    Other
    $5,470
    Deferred
    $465,334
    Nontaxable benefits
    $40,367
    Filer's total
    $2,266,858
  • Tracey Merchant

    CFO & EVP, Administration

    Total calculated
    $1,717,156
    From this org
    $1,340,588
    From related orgs
    $0
    Other
    $376,568
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $600,224
    Bonus
    $636,820
    Other
    $103,544
    Deferred
    $337,537
    Nontaxable benefits
    $39,031
    Filer's total
    $1,717,156
  • Elizabeth Carpenter

    EVP, Policy/Research

    Total calculated
    $1,754,111
    From this org
    $1,077,102
    From related orgs
    $0
    Other
    $677,009
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $631,118
    Bonus
    $443,404
    Other
    $2,580
    Deferred
    $672,556
    Nontaxable benefits
    $4,453
    Filer's total
    $1,754,111
  • Lori Reilly

    COO

    Total calculated
    $4,523,351
    From this org
    $2,547,833
    From related orgs
    $0
    Other
    $1,975,518
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $1,100,452
    Bonus
    $1,443,151
    Other
    $4,230
    Deferred
    $1,931,043
    Nontaxable benefits
    $44,475
    Filer's total
    $4,523,351
  • Renuka Iyer

    EVP, Human Resources

    Total calculated
    $938,162
    From this org
    $652,356
    From related orgs
    $0
    Other
    $285,806
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $437,442
    Bonus
    $209,024
    Other
    $5,890
    Deferred
    $255,500
    Nontaxable benefits
    $30,306
    Filer's total
    $938,162
  • Robert Zirkelbach II

    EVP, Public Affairs

    Total calculated
    $1,881,642
    From this org
    $1,190,211
    From related orgs
    $0
    Other
    $691,431
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $635,243
    Bonus
    $547,240
    Other
    $7,728
    Deferred
    $652,831
    Nontaxable benefits
    $38,600
    Filer's total
    $1,881,642
  • Shannon Monsif

    EVP, Alliance

    Total calculated
    $1,478,984
    From this org
    $1,115,048
    From related orgs
    $0
    Other
    $363,936
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $544,971
    Bonus
    $541,782
    Other
    $28,295
    Deferred
    $314,920
    Nontaxable benefits
    $49,016
    Filer's total
    $1,478,984
  • Steven Tilton

    EVP, Federal Advocacy

    Total calculated
    $1,908,566
    From this org
    $920,326
    From related orgs
    $0
    Other
    $988,240
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $615,096
    Bonus
    $301,000
    Other
    $4,230
    Deferred
    $947,000
    Nontaxable benefits
    $41,240
    Filer's total
    $1,908,566
  • Anne Pritchett

    SVP, Policy/Research

    Total calculated
    $2,106,207
    From this org
    $2,066,592
    From related orgs
    $0
    Other
    $39,615
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $87,628
    Bonus
    $927,884
    Other
    $1,051,080
    Deferred
    $34,500
    Nontaxable benefits
    $5,115
    Filer's total
    $2,106,207
  • Jay Taylor

    EVP, International

    Total calculated
    $1,338,685
    From this org
    $990,116
    From related orgs
    $0
    Other
    $348,569
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $528,490
    Bonus
    $443,847
    Other
    $17,779
    Deferred
    $304,277
    Nontaxable benefits
    $44,292
    Filer's total
    $1,338,685
  • Kenneth K McKay IV

    SVP, State Advocacy

    Total calculated
    $1,221,209
    From this org
    $935,523
    From related orgs
    $0
    Other
    $285,686
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $514,751
    Bonus
    $410,702
    Other
    $10,070
    Deferred
    $244,696
    Nontaxable benefits
    $40,990
    Filer's total
    $1,221,209
  • Michael Woody

    SVP, Federal Advocacy

    Total calculated
    $1,464,681
    From this org
    $1,175,941
    From related orgs
    $0
    Other
    $288,740
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $519,097
    Bonus
    $654,704
    Other
    $2,140
    Deferred
    $246,500
    Nontaxable benefits
    $42,240
    Filer's total
    $1,464,681
  • Scott LaGanga

    EVP, State Advocacy

    Total calculated
    $1,574,509
    From this org
    $1,199,864
    From related orgs
    $0
    Other
    $374,645
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $581,008
    Bonus
    $613,766
    Other
    $5,090
    Deferred
    $330,551
    Nontaxable benefits
    $44,094
    Filer's total
    $1,574,509
  • Jennifer Bryant

    EVP, Policy/Research

    Total calculated
    $1,858,936
    From this org
    $1,858,936
    From related orgs
    $0
    Other
    $0
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $0
    Bonus
    $0
    Other
    $1,858,936
    Deferred
    $0
    Nontaxable benefits
    $0
    Filer's total
    $1,858,936

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 1a · First-class or charter travel
  • 1a · Travel for companions
  • 1a · Tax indemnification and gross-up payments
  • 1a · Housing allowance or residence for personal use
  • 1a · Health or social club dues or initiation fees
  • 1a · Personal services (maid, chauffeur, chef)
  • 1b · Written policy on the line-1a expenses
  • 2 · Substantiation required before reimbursing expenses
  • 3 · Compensation committee
  • 3 · Independent compensation consultant
  • 3 · Form 990 of other organizations
  • 3 · Written employment contract
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement

Answered no

  • 4a · Severance or change-of-control payment

The filer's explanations (Part III)

Schedule J, Part I, Line 1a First-class or charter travel
FIRST CLASS TRAVEL: THE PRESIDENT AND COO ARE AUTHORIZED TO TRAVEL USING FIRST CLASS.
Schedule J, Part I, Line 1a Travel for companions
TRAVEL FOR COMPANIONS: COMPANIONS OCCASIONALLY TRAVEL WITH PHRMA EXECUTIVES ON BUSINESS TRAVEL. IN SUCH CASES, COMPANION TRAVEL IS INCLUDED IN THE TAXABLE INCOME OF THE PHRMA EXECUTIVE.
Schedule J, Part I, Line 1a Housing allowance or residence for personal use
HOUSING ALLOWANCE: A HOUSING ALLOWANCE IS PROVIDED TO TRACEY MERCHANT, CFO & EVP, ADMINISTRATION. IT IS PAID MONTHLY AND INCLUDED IN HER INCOME ON FORM W-2.
Schedule J, Part I, Line 1a Health or social club dues or initiation fees
HEALTH AND WELLNESS BENEFIT: ALL PHRMA EMPLOYEES ARE ELIGIBLE TO PARTICIPATE IN PHRMA'S HEALTH AND WELLNESS BENEFIT UP TO $1,250 ANNUALLY. THE VALUE OF THIS BENEFIT IS CONSIDERED TAXABLE INCOME.
Schedule J, Part I, Line 1a Personal services
PERSONAL SERVICES: THE PRESIDENT IS PROVIDED WITH A DRIVER.
Schedule J, Part I, Line 4b Supplemental nonqualified retirement plan
SUPPLEMENTAL PAYMENT PLAN RETIREMENT BENEFIT: ANNE PRITCHETT - $1,041,074, JENNIFER BRYANT - $1,848,016 457(F) AND LTIP: PHRMA SPONSORS A NON-QUALIFIED SECTION 457(F) DEFERRED COMPENSATION PLAN AND A LONG-TERM INCENTIVE PLAN. AMOUNTS PAID OUT UNDER THESE PLANS ARE INCLUDED IN PART VII (WHEN PAID) AND SCHEDULE J, RESPECTIVELY (WHEN PAID, EARNED AND REPORTED IN A PRIOR YEAR). PRIOR YEAR PAID CURRENT YEAR AWARDED STEPHEN UBL: $ 1,823,682 $ 1,635,015 LORI REILLY: $ 708,109 $ 916,043 JAMES STANSEL: $ 480,841 $ 430,834 SCOTT LAGANGA: $ 252,470 $ 296,051 TRACEY MERCHANT: $ - $ 303,037 SHANNON MONSIF: $ 241,441 $ 280,420 ROBERT ZIRKELBACH II: $ - $ 321,781 ELIZABETH CARPENTER: $ - $ 316,506 ANNE PRITCHETT: $ 397,102 $ - JAY TAYLOR: $ - $ 269,777 KENNETH K MCKAY IV: $ - $ 210,196 RENUKA IYER: $ - $ 221,000 STEVEN TILTON: $ -$ 312,500 MICHAEL WOODY: $ - $ 212,000
Schedule J, Part I, Line 4c Equity-based compensation arrangement
See Line 4B for details.

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

The 10 largest by cash amount. The API serves every itemized grant.

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

  • PHRMA PAC

    527 · POLITICAL · CA · controlled entity

    Directly controlled by PHRMA

  • PHRMA INDEPENDENT EXPENDITURE COMMITTEE

    527 · POLITICAL · CA · controlled entity

    Directly controlled by PHRMA

  • PHRMA COLORADO ACTION FUND

    527 · POLITICAL · CO · controlled entity

    Directly controlled by PHRMA

  • PHRMA BETTER GOVERNMENT COMMITTEE

    527 · POLITICAL · DC · controlled entity

    Directly controlled by PHRMA

  • PHRMA TN PAC

    527 · POLITICAL · TN · controlled entity

    Directly controlled by PHRMA

  • PhRMA California Initiative Fund

    527 · POLITICAL · CA · controlled entity

    Directly controlled by PHRMA

  • HEALTHY NEVADA PAC

    527 · POLITICAL · NV · controlled entity

    Directly controlled by PHRMA

  • PHRMA PNW PAC

    527 · POLITICAL · ID · controlled entity

    Directly controlled by PHRMA

Provenance

Return type
form_990
Tax year
2024
Filed
14 November 2025
IRS schema version
2024v5.1
Source object
202503189349303315

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.